ornithine has been researched along with Invasiveness, Neoplasm in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
D'Alessio, S; Kraev, I; Lange, S; Mortoglou, M; Uysal-Onganer, P | 1 |
Antognelli, C; Cecchetti, R; Peirce, MJ; Riuzzi, F; Talesa, VN | 1 |
Ding, D; Liu, XM; Pan, C; Xia, YM; Zhan, N; Zou, XY | 1 |
3 other study(ies) available for ornithine and Invasiveness, Neoplasm
Article | Year |
---|---|
Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Extracellular Vesicles; Humans; Isoenzymes; Neoplasm Invasiveness; Ornithine; Pancreatic Neoplasms; Prohibitins; Protein-Arginine Deiminase Type 2; Protein-Arginine Deiminase Type 3; Protein-Arginine Deiminase Type 4 | 2021 |
Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control.
Topics: 3' Untranslated Regions; Aged; Base Sequence; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Homoarginine; Humans; Imidazoles; Lactoylglutathione Lyase; Male; Metformin; MicroRNAs; Middle Aged; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Ornithine; Phenotype; Prostatic Neoplasms; Pyrimidines; Signal Transduction; Smad Proteins; Thiolester Hydrolases; Transforming Growth Factor beta1 | 2018 |
Glyoxalase I is differentially expressed in cutaneous neoplasms and contributes to the progression of squamous cell carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Disease Progression; Humans; Lactoylglutathione Lyase; Male; Mice; Neoplasm Invasiveness; NF-kappa B; Ornithine; Pyrimidines; Pyruvaldehyde; Skin Neoplasms; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |